SCM
IMNM icon

Sterling Capital Management’s Immunome IMNM Stock Holding History

Sterling Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.84K Sell
370
-293
-44% -$6.27K ﹤0.01% 2354
2026
Q1 		$14.5K Buy
663
+51
+8% +$1.14K ﹤0.01% 2179
2025
Q4 		$13.1K Buy
612
+425
+227% +$7.46K ﹤0.01% 2471
2025
Q3 		$2.19K Buy
187
+7
+4% +$70 ﹤0.01% 2961
2025
Q2 		$1.67K Buy
180
+106
+143% +$869 ﹤0.01% 2963
2025
Q1 		$498 Buy
74
+21
+40% +$201 ﹤0.01% 2957
2024
Q4 		$563 Hold
53
– – ﹤0.01% 3019
2024
Q3 		$775 Buy
+53
New +$753 ﹤0.01% 2670

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Sterling Capital Management's IMNM Position: Q2 2026 in Review

Sterling Capital Management reduced its Immunome (IMNM) stake by 44% in Q2 2026, selling an estimated $6.27K and leaving 370 shares worth $7.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Sterling Capital Management first reported a position in IMNM in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.5K in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Sterling Capital Management held 370 shares of Immunome worth $7.84K as of Q2 2026.
  • Sterling Capital Management sold 293 Immunome shares in Q2 2026, an estimated $6.27K.
  • Immunome made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2354 holding.
  • Sterling Capital Management first reported a position in Immunome in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Immunome position peaked at $14.5K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.